Efalizumab for the treatment of refractory hidradenitis suppurativa

Journal of the American Academy of Dermatology

Volumn 57, Issue 6, 2007, Pages 1090-1091

  Strober, Bruce E ^a   Kim, Carolyn ^a   Siu, Kimberly ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AMINOLEVULINIC ACID; CORTICOSTEROID; EFALIZUMAB; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; RETINOID;

ARTICLE; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG WITHDRAWAL; ENDOTHELIUM CELL; HUMAN; INTRADUCTAL CARCINOMA; LYMPHOCYTE MIGRATION; MIGRAINE; PAPULE; PRIORITY JOURNAL; PUSTULE; SKIN NODULE; SUPPURATIVE HIDRADENITIS; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS; MIDDLE AGED;

EID: 36048994924     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.07.032     Document Type: Article

References (5)

1. Joseph M.A., Jayaseelan E., Ganapathi B., and Stephen J. Hidradenitis suppurativa treated with finasteride. J Dermatol Treat 16 (2005) 75-78
2. Rosi Y.L., Lowe L., and Kang S. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease. J Dermatol Treat 16 (2005) 58-61
3. Cusack C., and Buckley C. Etanercept: effective in the management of hidradenitis suppurativa. Br J Dermatol 154 (2006) 726-729
4. Moul D.K., and Korman N.J. Severe hidradenitis suppurativa treated with adalimumab. Arch Dermatol 142 (2006) 1110-1112
5. Gold M., Bridges T.M., Bradshaw V.L., and Boring M. ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol 3 1 Suppl (2004) S32-S35